Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
10.18
+0.03 (0.30%)
Jun 9, 2026, 3:49 PM EST
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $40.31 billion as of June 10, 2026. Its market cap has increased by 45.19% in one year.
Market Cap
40.31B
Enterprise Value
77.70B
Revenue
52.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.18
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 40.31B, an increase of 587.86%. That is a compound annual growth rate of 5.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 40.49B | -5.34% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 1.05B |
| Veradigm | 544.95M |
| Elite Pharmaceuticals | 416.06M |
| American Oncology Network | 404.79M |
| CytoDyn | 401.44M |
| Glorywin Entertainment Group | 343.05M |
| Northwest Biotherapeutics | 337.50M |
| Silence Therapeutics | 291.44M |